(S)-Octahydropyrrolo[1,2-a]pyrazine dihydrochloride is a bicyclic secondary amine derivative, specifically a chiral piperazine-pyrrolidine fused heterocycle. It serves as a crucial chiral building block in pharmaceutical synthesis, particularly valued for its constrained, rigid scaffold which can mimic peptide secondary structures. Its primary application is as a key intermediate in the synthesis of complex drug candidates. Most notably, it is a core structural component in the production of HCV NS5A inhibitors, such as daclatasvir and related compounds. The (S)-enantiomer provides the specific stereochemistry required for high biological activity. This scaffold is also explored in the design of peptidomimetics and other bioactive molecules targeting various diseases. The compound is typically handled as a stable, crystalline dihydrochloride salt to improve its handling and solubility properties in synthetic processes. It is commercially available from suppliers specializing in advanced pharmaceutical intermediates and chiral building blocks for medicinal chemistry.